Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Walgreens reaches $500 million deal with New Mexico over opioid crisis
Published Jun 09, 2023 11:13AM ET
Updated Jun 09, 2023 12:55PM ET
© Reuters. FILE PHOTO: People walk by a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly
By Brendan Pierson
(Reuters) -Walgreens Boots Alliance has agreed to pay $500 million to New Mexico to settle claims that its pharmacies helped fuel opioid addiction in the state by failing to stop illegal pill sales, lawyers for the state announced on Friday.
The settlement, the largest obtained by New Mexico against a single company over opioids, came after a non-jury trial last year in the state's lawsuit against the company. The judge overseeing that trial had not yet ruled on the state's claims.
"We are confident that this record settlement positions New Mexico to turn the tide on this deadly epidemic," Mark Pifko, a lawyer for the state, said in a statement.
New Mexico has now settled all of its major opioid-related lawsuits, recovering more than $1 billion including Friday's deal, Pifko said.
Walgreens did not admit wrongdoing in the settlement. A spokesperson for the company declined to comment.
More than half a million people died from drug overdoses in the United States from 1999 to 2020, with opioids playing an outsized role. Overdose deaths have risen further since then, according to data from the U.S. Centers for Disease Control and Prevention.
New Mexico's lawsuit against Walgreens was one of more than 3,300 filed by state and local governments accusing pharmacies and distributors of ignoring red flags that opioids were being diverted to the black market, and drugmakers of downplaying the risks of the addictive pain drugs.
The litigation, now winding down, has resulted in more than $50 billion in settlements, including a $5.7 billion nationwide deal between states and Walgreens in which New Mexico did not take part.
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.